We are live on ! Find out more
Name Funds
holding
Growth Growth % Return since
30 Jun ‘26
AXIN
9301
Axiom Intelligence Acquisition Corp 1
AXIN
47 -8 -15%
TVA
9302
Texas Ventures Acquisition III Corp
TVA
$316M
47 -8 -15% 0.09%
UPXI icon
9303
Upexi
UPXI
$54.9M
47 -8 -15% 4.68%
SZZL
9304
Sizzle Acquisition Corp II
SZZL
$326M
47 -8 -15% 0.58%
CHRS icon
9305
Coherus Oncology
CHRS
$185M
135 -23 -15% 14.3%
CHGG icon
9306
Chegg
CHGG
$87.5M
88 -15 -15% 22%
NUS icon
9307
Nu Skin
NUS
$234M
152 -26 -15% 9.09%
RGNX icon
9308
Regenxbio
RGNX
$711M
152 -26 -15% 10.1%
OCTU
9309
AllianzIM U.S. Equity Buffer15 Uncapped Oct ETF
OCTU
$61.2M
35 -6 -15% 3.16%
SVCC
9310
Stellar V Capital Corp
SVCC
35 -6 -15%
EGAN icon
9311
eGain
EGAN
$206M
99 -17 -15% 19%
FIS icon
9312
Fidelity National Information Services
FIS
$22.1B
803 -138 -15% 10.4%
CGTX icon
9313
Cognition Therapeutics
CGTX
$96M
64 -11 -15% 12.2%
NBBK icon
9314
NB Bancorp
NBBK
$1.01B
151 -26 -15% 8.76%
TMDX icon
9315
Transmedics
TMDX
$3.07B
354 -61 -15% 33.4%
FCRS
9316
FutureCrest Acquisition Corp
FCRS
$368M
58 -10 -15% 0.68%
HII icon
9317
Huntington Ingalls Industries
HII
$12.9B
765 -132 -15% 17.1%
SA
9318
Seabridge Gold
SA
$3.62B
168 -29 -15% 30.2%
RNA
9319
Atrium Therapeutics
RNA
$220M
139 -24 -15% 4.54%
IIM icon
9320
Invesco Value Municipal Income Trust
IIM
$602M
81 -14 -15% 0.47%
TACO
9321
Berto Acquisition Corp
TACO
$392M
52 -9 -15% 0.38%
DDL
9322
Dingdong
DDL
$523M
52 -9 -15% 23.8%
ENGN icon
9323
enGene Therapeutics
ENGN
$114M
52 -9 -15% 1.73%
MSTR icon
9324
Strategy Inc
MSTR
$36.6B
802 -139 -15% 7.03%
CEPV
9325
Cantor Equity Partners V
CEPV
75 -13 -15%